Want to see SNYRQ full AI Analyst Report?

Synergy CHC (SNYRQ) Price & Analysis

121 Followers

SNYRQ Stock Chart & Stats

$0.10

<$0.01(1.97%)

At close: Jul 24 4:00 PM EDT

$0.10

<$0.01(1.97%)

Day’s Range― - ―

52-Week Range$0.02 - $2.96

Previous CloseN/A

VolumeN/A

Average Volume (3M)63.99M

Market Cap

$415.71K

Enterprise Value$41.94

Total Cash (Recent Filing)$292.12K

Total Debt (Recent Filing)$27.75M

Price to Earnings (P/E)―

Beta0.38

Next Earnings

Nov 12, 2026

EPS Estimate

0.01

Next Dividend Ex-DateN/A

Dividend YieldN/A

Share Statistics

EPS (TTM)-1.60

Shares Outstanding14,899,883

10 Day Avg. Volume162,863,089

30 Day Avg. Volume63,988,986

Financial Highlights & Ratios

PEG Ratio<0.01

Price to Book (P/B)-0.78

Price to Sales (P/S)0.60

P/FCF Ratio-7.00

Enterprise Value/Market Cap<0.01

Enterprise Value/Revenue<0.01

Enterprise Value/Gross Profit<0.01

Enterprise Value/Ebitda>-0.01

Forecast

1Y Price TargetN/A

Price Target UpsideN/A

Rating ConsensusN/A

Number of Analyst Covering0

EPS Forecast (FY)-0.19

Revenue Forecast (FY)$32.00M

Bulls Say, Bears Say

Bulls Say

High, Stable Gross MarginA gross margin near 67% indicates the company retains substantial value after direct costs, providing an underlying economic base for the business. However, the benefit is currently being offset by operating expenses and other costs that prevent conversion into sustainable earnings.

Narrowing Free-cash-flow LossThe narrowing free-cash-flow deficit represents a measured improvement in cash performance compared with 2024. Although cash generation remains negative, this trend could reduce the pace of cash consumption if maintained, supporting greater financial resilience over the next several quarters.

Some Cash-flow ImprovementImprovement from the prior year suggests the company has made some progress in limiting cash losses, which is relevant to its ability to stabilize operations. The improvement is not yet sufficient for self-funding, but it provides a constructive direction if sustained across future reporting periods.

Bears Say

Declining RevenueA shrinking revenue base can weaken operating leverage and reduce the scale available to absorb fixed costs. Continued contraction would make it harder for Synergy CHC to leverage its relatively high gross margin, sustain investment, and restore profitability over the coming quarters.

Severe Profitability DeteriorationDeeply negative net margin, operating profit, and EBITDA show that the company is not converting gross profit into sustainable operating earnings. Persistent losses can consume capital, constrain reinvestment, and make recovery dependent on materially improving cost structure or revenue performance.

Highly Stressed Balance SheetDebt that substantially exceeds assets, combined with consistently negative equity, indicates a severely impaired capital base and limited financial flexibility. This structure increases solvency pressure and restricts the company’s ability to fund operations, reduce debt, or absorb further losses internally.

SNYRQ FAQ

What was Synergy CHC’s price range in the past 12 months?

Synergy CHC lowest stock price was $0.01 and its highest was $2.96 in the past 12 months.

What is Synergy CHC’s market cap?

Synergy CHC’s market cap is $415.71K.

When is Synergy CHC’s upcoming earnings report date?

Synergy CHC’s upcoming earnings report date is Nov 12, 2026 which is in 49 days.

How were Synergy CHC’s earnings last quarter?

Synergy CHC released its earnings results on Apr 01, 2026. The company reported -$0.23 earnings per share for the quarter, missing the consensus estimate of $0.03 by -$0.26.

Is Synergy CHC overvalued?

According to Wall Street analysts Synergy CHC’s price is currently Overvalued. Get more investment ideas with TipRanks Premium

Does Synergy CHC pay dividends?

Synergy CHC does not currently pay dividends.

What is Synergy CHC’s EPS estimate?

Synergy CHC’s EPS estimate is 0.01.

How many shares outstanding does Synergy CHC have?

Synergy CHC has 14,899,883 shares outstanding.

What happened to Synergy CHC’s price movement after its last earnings report?

Synergy CHC reported an EPS of -$0.23 in its last earnings report, missing expectations of $0.03. Following the earnings report the stock price went down -8.667%.

Which hedge fund is a major shareholder of Synergy CHC?

Currently, no hedge funds are holding shares in SNYRQ

What is the TipRanks Smart Score and how is it calculated?

Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

Company Description

Synergy CHC

Synergy CHC Corp. operates as a distributor of diverse consumer health, beauty, and lifestyle merchandise across the United States, Canada, and the United Kingdom. The company's brand portfolio features FOCUSfactor, specializing in nutritional supplements aimed at enhancing brain function. It also offers the Flat Tummy line, which includes a range of wellness and fashion items such as specialty teas, meal replacement shakes, lollipops, dietary aids, apparel, and exercise accessories. Furthermore, under the Hand MD brand, Synergy CHC Corp. provides anti-aging skincare products, encompassing serums and creams designed for exfoliation, skin repair, and rehydration, as well as hand hygiene products like soaps and sanitizers. These goods are made available to consumers through conventional retail partners and significant television advertising campaigns. The company's skincare range, in particular, is also sold directly via online platforms. Founded in 2010, the firm was originally named Synergy Strips Corp. and rebranded to Synergy CHC Corp. in August 2015. Its primary business operations are based in Westbrook, Maine.